References
- Sackett D. L. Rules of evidence and clinical recommendations on the use of antithrombotic agents. CHEST, 1989, (95) 2 suppl. 2s-4s.
- Solomon M. J., McLoud R. S. Should we be performing more randomised controlled trials evaluating surgical operations ? Surgery, 1995, 118: 459–67.
- Morgan W. K. On evidence embellishment and efficacy. J Eval Clin Pract, 1997: 2117–22.
- Jungajns C., Feder G., Hemmingway H. et al. Recruiting patients to medical research. Double blind randomised trial of ‘Opt in’ versus ‘opt out’ strategies. Br Med J, 2005, 331: 940–42.
- Willenheimer R. Statistical significance versus clinical relevance in cardiovascular medicine. Prog Cardiovasc Dis, 2001, 44: 15567.
- Yadav J. S., Wholey M. H., Kuntz R. E. et al. Protected carotid artery stenting versus endarterectomy in high risk patients. N Eng J Med, 2004, 351: 1493–1501.
- MRC Asymptomatic Carotid Surgery Trial ACST (collective group). Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms. A randomised controlled trial. Lancet, 2004, 363: 1491–1501.
- Boules T. N., Proctor M. C., Aref A. Carotid endarterectomy remains the standard of care even in high risk surgical patients. Ann Surg, 2005, 241: 356–63.
- North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with a high grade carotid stenosis. New Eng J Med, 1991, 325: 445–453.
- MRC European Carotid Surgery Trial. Interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. European Carotid Surgery Trialist Collaborative Group. Lancet, May 25, 1991, 1235–1243.
- Rothwell P. M., Coull A. J., Giles M. F. et al. Change in stroke incidence mortality, case fatality, severity and risk factors in Oxfordshire, UK from, 1981–2004 (Oxford Vascular Study). Lancet, 2004, 363: 1925–1933.